October 9, 2026

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Growth Amidst Market Challenges

Fortrea Holdings Inc. (NASDAQ: FTRE) stands as a notable entity within the biotechnology industry, offering a spectrum of development solutions for biopharmaceutical products and medical devices. As a contract research..

Tyra Biosciences (TYRA) Stock Analysis: Unveiling a 137% Upside Potential in the Biotechnology Sector

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology firm focused on developing precision medicines targeting fibroblast growth factor receptor (FGFR) biology, presents an intriguing opportunity for investors within the healthcare..

Abivax SA (ABVX) Stock Analysis: Potential 84% Upside with Strong Buy Ratings and Promising Drug Pipeline

For investors seeking opportunities in the biotechnology sector, Abivax SA (ABVX) presents a compelling case with its significant upside potential and a unanimous positive outlook from analysts. Headquartered in Paris,..

Altimmune, Inc. (ALT) Stock Analysis: A Potential 558% Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is currently making waves in the healthcare sector with its focus on innovative therapies for serious liver diseases. With a market capitalization..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Navigating the 56.25% Upside Potential

Investors eyeing opportunities in the healthcare sector may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect, especially given its potential upside of 56.25% based on current analyst target prices...

MBX Biosciences, Inc. (MBX) Investor Outlook: 77% Potential Upside as Phase 3 Trials Advance

MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, is capturing investor attention with a promising 77.09% potential upside, according to the latest analyst ratings. This biotechnology firm, based in..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: A 41.94% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is garnering attention within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $252.01 million, this United States-based company..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 38.69% Potential Upside in the Medical Device Market

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, has captured the attention of investors with its potential for substantial stock appreciation. This Durham,..

Celcuity Inc. (CELC) Stock Analysis: A Biotech Gem with 131% Upside Potential

Celcuity Inc. (NASDAQ: CELC) is gaining significant attention in the biotechnology sector, not just for its cutting-edge research in cancer therapies but also for its promising market potential. The company..

InnovAge Holding Corp. (INNV) Stock Analysis: A Closer Look at Growth Potential Amidst Market Fluctuations

InnovAge Holding Corp. (NASDAQ: INNV) is a player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.24 billion, InnovAge focuses on delivering..

Upstream Bio, Inc. (UPB) Stock Analysis: A 584.46% Upside Potential in the Biotech Space

Upstream Bio, Inc. (UPB), a clinical-stage biotechnology company, has caught the attention of investors with a staggering potential upside of 584.46%, according to the latest analyst ratings. Operating within the..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 202% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, has recently caught the attention of investors due to its promising potential for substantial stock price appreciation. Currently..

Claritev Corporation (CTEV) Stock Analysis: Exploring an 89% Upside Potential

Investors with an eye on the healthcare sector may find Claritev Corporation (CTEV) particularly intriguing, especially given its impressive potential upside of 89.07%. Operating within the Health Information Services industry,..

SIGA Technologies Inc. (SIGA) Stock Analysis: Insight into Current Challenges and Opportunities

Investors eyeing SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, are met with a mixed bag of financial metrics that warrant a closer look. With a..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Navigating Biotech’s Potential with a 38.94% Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology innovator, is capturing the attention of investors with its cutting-edge approach to developing antibody-based medicines. Despite the recent volatility in its stock..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 541% Potential Upside Amidst Biotech Advances

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors, not just for its innovative approach in the biotech sector, but also for its eye-catching potential upside of 541.03%. With..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Exploring a 37.65% Potential Upside

Sonida Senior Living, Inc. (SNDA) is a prominent player in the healthcare sector, focusing on medical care facilities specifically tailored for senior housing communities in the United States. With a..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges Amidst Biotechnology Innovation

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) sits at the intersection of biotechnology and innovation, offering a compelling yet challenging landscape for investors. As a trailblazer in the cell engineering sector,..

REGENXBIO Inc. (RGNX) Investor Outlook: Unpacking a 191.51% Potential Upside

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector with a promising prospect for investors seeking substantial growth potential. This clinical-stage company, headquartered in Rockville, Maryland, is at the..

Search

Funds

October 9, 2026

Search

Funds

October 9, 2026

FTSE 100

Funds